Genetics of temporal lobe epilepsy

Brain and Development

Volumn 34, Issue 8, 2012, Pages 609-616

  Hwang, Su Kyeong ^a   Hirose, Shinichi ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

ADLTE; FMTLE; FPEVF; Genetics; Mutation; Temporal lobe epilepsy

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; ABC TRANSPORTER; ADAM22 PROTEIN; ADENOSINE TRIPHOSPHATE; BRAIN DERIVED NEUROTROPHIC FACTOR; FIBROBLAST GROWTH FACTOR 2; GLYCOPROTEIN P; INWARDLY RECTIFYING POTASSIUM CHANNEL KCNAB1; LEUCINE RICH GLIOMA INACTIVATED 1 PROTEIN; METALLOPROTEINASE; NEUROPEPTIDE Y; POTASSIUM CHANNEL; POTASSIUM CHANNEL KV1.1; POTASSIUM CHANNEL KV1.4; PRODYNORPHIN; UNCLASSIFIED DRUG;

AUTOSOMAL DOMINANT LATERAL TEMPORAL LOBE EPILEPSY; BENIGN FAMILIAL INFANTILE CONVULSION; CHILDHOOD ABSENCE EPILEPSY; CLINICAL FEATURE; DNA POLYMORPHISM; DRUG RESISTANT MESIAL TEMPORAL LOBE EPILEPSY; DRUG TRANSPORT; EPILEPSY; EXCITATORY POSTSYNAPTIC POTENTIAL; FAMILIAL MESIAL TEMPORAL LOBE EPILEPSY; FAMILIAL MESIAL TEMPORAL LOBE EPILEPSY WITH FEBRILE SEIZURE; FAMILIAL MESIAL TEMPORAL LOBE EPILEPSY WITH HIPPOCAMPAL SCLEROSIS; FAMILIAL PARTIAL EPILEPSY WITH VARIABLE FOCI; GENE DELETION; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENE PRODUCT; GENE THERAPY; GENETIC MARKER; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETICS; HUMAN; IDIOPATHIC GENERALIZED EPILEPSY; NONHUMAN; REVIEW; RISK ASSESSMENT; TEMPORAL LOBE EPILEPSY;

ANIMALS; EPILEPSY, TEMPORAL LOBE; GENE EXPRESSION REGULATION; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC THERAPY; HUMANS;

EID: 84864740388     PISSN: 03877604     EISSN: 18727131     Source Type: Journal    
DOI: 10.1016/j.braindev.2011.10.008     Document Type: Review

References (91)

1. Panayiotopoulos C.P. The Epilepsies: Seizures, Syndromes and Management 2005, Bladon Medical Publishing, Oxfordshire(UK).
2. de Moura JC, Tirapelli DP, Neder L, Saggioro FP, Sakamoto AC, Velasco TR, et al. Amygdala gene expression of NMDA and GABA(A) receptors in patients with mesial temporal lobe epilepsy. Hippocampus [online] 2010. [accessed 2010 April 10]. URL: http://onlinelibrary.wiley.com/doi/10.1002/hipo.20863/citedby.
3. Harvey A.S., Berkovic S.F., Wrennall J.A., Hopkins I.J. Temporal lobe epilepsy in childhood: clinical EEG and neuroimaging findings and syndrome classification in a cohort with new-onset seizures. Neurology 1997, 49(4):960-968.
4. Ray A., Kotagal P. Temporal lobe epilepsy in children: overview of clinical semiology. Epileptic Disord 2005, 7(4):299-307.
5. Ottman R. Genetics of the partial epilepsies: a review. Epilepsia 1989, 30:107-111.
6. Berkovic S.F., McIntosh A., Howell R.A., Mitchell A., Sheffield L.J., Hopper J.L. Familial temporal lobe epilepsy: a common disorder identified in twins. Ann Neurol 1996, 40:227-235.
7. Vadlamudi L., Scheffer I.E., Berkovic S.F. Genetics of temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 2003, 74:1359-1361.
8. Gambardella A., Labate A., Giallonardo A., Aguglia U. Familial mesial temporal lobe epilepsies: clinical and genetic features. Epilepsia 2009, 50(Suppl 5):55-57.
9. Nobile C., Michelucci R., Andreazza S., Pasini E., Tosatto S.C., Striano P. LGI1 mutations in autosomal dominant and sporadic lateral temporal epilepsy. Hum Mutat 2009, 30:530-536.
10. Ottman R. Autosomal Dominant Partial Epilepsy with Auditory Features. GeneReviews [Online]. 2010. [accessed 2010 April 15]. URL:. http://www.ncbi.nlm.nih.gov/pubmed/20301709.
11. Kalachikov S., Evgrafov O., Ross B., Winawer M., Barker-Cummings C., Martinelli Boneschi F., et al. Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat Genet 2002, 30:335-341.
12. Senechal K.R., Thaller C., Noebels J.L. ADPEAF mutations reduce levels of secreted LGI1 a putative tumor suppressor protein linked to epilepsy. Hum Mol Genet 2005, 14:1613-1620.
13. Schulte U., Thumfart J.O., Klocker N., Sailer C.A., Bildl W., Biniossek M., et al. The epilepsy-linked Lgi1 protein assembles into presynaptic Kv1 channels and inhibits inactivation by Kvbeta1. Neuron 2006, 49:697-706.
14. Fukata Y., Adesnik H., Iwanaga T., Bredt D.S., Nicoll R.A., Fukata M. Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission. Science 2006, 313:1792-1795.
15. Sirerol-Piquer M.S., Ayerdi-Izquierdo A., Morante-Redolat J.M., Herranz-Perez V., Favell K., Barker P.A., et al. The epilepsy gene LGI1 encodes a secreted glycoprotein that binds to the cell surface. Hum Mol Genet 2006, 15:3436-3445.
16. Furlan S., Roncaroli F., Forner F., Vitiello L., Calabria E., Piquer-Sirerol S., et al. The LGI1/epitempin gene encodes two protein isoforms differentially expressed in human brain. J Neurochem 2006, 98:985-991.
17. Zhou Y.D., Lee S., Jin Z., Wright M., Smith S.E., Anderson M.P. Arrested maturation of excitatory synapses in autosomal dominant lateral temporal lobe epilepsy. Nat Med 2009, 15:1208-1214.
18. Morante-Redolat J.M., Gorostidi-Pagola A., Piquer-Sirerol S., Saenz A., Poza J.J., Galan J., et al. Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy. Hum Mol Genet 2002, 11:1119-1128.
19. Berkovic S.F., Serratosa J.M., Phillips H.A., Xiong L., Andermann E., Diaz-Otero F., et al. Familial partial epilepsy with variable foci: clinical features and linkage to chromosome 22q12. Epilepsia 2004, 45:1054-1060.
20. Michelucci R., Poza J.J., Sofia V., de Feo M.R., Binelli S., Bisulli F., et al. Autosomal dominant lateral temporal epilepsy: clinical spectrum new epitempin mutations and genetic heterogeneity in seven European families. Epilepsia 2003, 44:1289-1297.
21. Ottman R., Winawer M.R., Kalachikov S., Barker-Cummings C., Gilliam T.C., Pedley T.A., et al. LGI1 mutations in autosomal dominant partial epilepsy with auditory features. Neurology 2004, 62:1120-1126.
22. Bisulli F., Tinuper P., Avoni P., Striano P., Striano S., d'Orsi G., et al. Idiopathic partial epilepsy with auditory features (IPEAF): a clinical and genetic study of 53 sporadic cases. Brain 2004, 127:1343-1352.
23. Michelucci R., Mecarelli O., Bovo G., Bisulli F., Testoni S., Striano P., et al. A de novo LGI1 mutation causing idiopathic partial epilepsy with telephone-induced seizures. Neurology 2007, 68:2150-2151.
24. Pizzuti A., Flex E., Di Bonaventura C., Dottorini T., Egeo G., Manfredi M., et al. Epilepsy with auditory features: a LGI1 gene mutation suggests a loss-of-function mechanism. Ann Neurol 2003, 53:396-399.
25. Bisulli F., Tinuper P., Marini C., Avoni P., Carraro G., Nobile C. Partial epilepsy with prominent auditory symptoms not linked to chromosome 10q. Epileptic Disord 2002, 4:183-187.
26. Rosanoff M.J., Ottman R. Penetrance of LGI1 mutations in autosomal dominant partial epilepsy with auditory features. Neurology 2008, 71:567-571.
27. Crompton D.E., Scheffer I.E., Taylor I., Cook M.J., McKelvie P.A., Vears D.F., et al. Familial mesial temporal lobe epilepsy: a benign epilepsy syndrome showing complex inheritance. Brain 2010, 133:3221-3231.
28. Cendes F., Lopes-Cendes I., Andermann E., Andermann F. Familial temporal lobe epilepsy: a clinically heterogeneous syndrome. Neurology 1998, 50:554-557.
29. Kobayashi E., Lopes-Cendes I., Guerreiro C.A., Sousa S.C., Guerreiro M.M., Cendes F. Seizure outcome and hippocampal atrophy in familial mesial temporal lobe epilepsy. Neurology 2001, 56:166-172.
30. Hitiris N., Mohanraj R., Norrie J., Sills G.J., Brodie M.J. Predictors of pharmacoresistant epilepsy. Epilepsy Res 2007, 75(2-3):192-196.
31. Harvey A.S., Grattan-Smith J.D., Desmond P.M., Chow C.W., Berkovic S.F. Febrile seizures and hippocampal sclerosis: frequent and related findings in intractable temporal lobe epilepsy of childhood. Pediatr Neurol 1995, 12(3):201-206.
32. Semah F., Picot M.C., Adam C., Broglin D., Arzimanoglou A., Bazin B., et al. Is the underlying cause of epilepsy a major prognostic factor for recurrence?. Neurology 1998, 51(5):1256-1262.
33. Pittau F., Bisulli F., Mai R., Fares J.E., Vignatelli L., Labate A., et al. Prognostic factors in patients with mesial temporal lobe epilepsy. Epilepsia 2009, 50(Suppl 1):41-44.
34. Labate A., Ventura P., Gambardella A., Le Piane E., Colosimo E., Leggio U., et al. MRI evidence of mesial temporal sclerosis in sporadic "benign" temporal lobe epilepsy. Neurology 2006, 66(4):562-565.
35. Scott R.C., King M.D., Gadian D.G., Neville B.G., Connelly A. Hippocampal abnormalities after prolonged febrile convulsion: a longitudinal MRI study. Brain 2003, 126(Pt 11):2551-2557.
36. Kauffman M.A., Moron D.G., Consalvo D., Bello R., Kochen S. Association study between interleukin 1 beta gene and epileptic disorders: a HuGe review and meta-analysis. Genet Med 2008, 10:83-88.
37. Kanemoto K., Kawasaki J., Miyamoto T., Obayashi H., Nishimura M. Interleukin (IL)1beta IL-1alpha and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy. Ann Neurol 2000, 47:571-574.
38. Buono R.J., Ferraro T.N., O'Connor M.J., Sperling M.R., Ryan S.G., Scattergood T., et al. Lack of association between an interleukin 1 beta (IL-1beta) gene variation and refractory temporal lobe epilepsy. Epilepsia 2001, 42:782-784.
39. Heils A., Haug K., Kunz W.S., Fernandez G., Horvath S., Rebstock J. Interleukin-1beta gene polymorphism and susceptibility to temporal lobe epilepsy with hippocampal sclerosis. Ann Neurol 2000, 48:948-950.
40. Salzmann A., Perroud N., Crespel A., Lambercy C., Malafosse A. Candidate genes for temporal lobe epilepsy: a replication study. Neurol Sci 2008, 29:397-403.
41. Stogmann E., Zimprich A., Baumgartner C., Aull-Watschinger S., Hollt V., Zimprich F. A functional polymorphism in the prodynorphin gene promotor is associated with temporal lobe epilepsy. Ann Neurol 2002, 51:260-263.
42. Tilgen N., Rebstock J., Horvath S., Propping P., Elger C.E., Heils A. Prodynorphin gene promoter polymorphism and temporal lobe epilepsy. Ann Neurol 2003, 53:281-282.
43. Jack C.R., Petersen R.C., Xu Y.C., O'Brien P.C., Waring S.C., Tangalos E.G., et al. Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease. Ann Neurol 1998, 43:303-310.
44. Barber R., Gholkar A., Scheltens P., Ballard C., McKeith I.G., Morris C.M., et al. Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias. Arch Neurol 1999, 56:961-965.
45. Mori E., Lee K., Yasuda M., Hashimoto M., Kazui H., Hirono N., et al. Accelerated hippocampal atrophy in Alzheimer's disease with apolipoprotein E epsilon4 allele. Ann Neurol 2002, 51:209-214.
46. Briellmann R.S., Torn-Broers Y., Busuttil B.E., Major B.J., Kalnins R.M., Olsen M., et al. APOE epsilon4 genotype is associated with an earlier onset of chronic temporal lobe epilepsy. Neurology 2000, 55:435-437.
47. Gambardella A., Aguglia U., Cittadella R., Romeo N., Sibilia G., LePiane E., et al. Apolipoprotein E polymorphisms and the risk of nonlesional temporal lobe epilepsy. Epilepsia 1999, 40:1804-1807.
48. Gambardella A., Manna I., Labate A., Chifari R., La Russa A., Serra P., et al. GABA(B) receptor 1 polymorphism (G1465A) is associated with temporal lobe epilepsy. Neurology 2003, 60:560-563.
49. Labate A., Manna I., Gambardella A., Le Piane E., La Russa A., Condino F., et al. Association between the M129V variant allele of PRNP gene and mild temporal lobe epilepsy in women. Neurosci Lett 2007, 421:1-4.
50. Wang X., Sun W., Zhu X., Wu X., Li L., Zhu S., et al. M129V polymorphism in the prion protein gene is not associated with mesial temporal lobe epilepsy in a Han Chinese population. Eur J Neurol 2008, 15:827-830.
51. Perosa S.R., Arganaraz G.A., Goto E.M., Costa L.G., Konno A.C., Varella P.P., et al. Kinin B1 and B2 receptors are overexpressed in the hippocampus of humans with temporal lobe epilepsy. Hippocampus 2007, 17:26-33.
52. van Gassen K.L., de Wit M., Koerkamp M.J., Rensen M.G., van Rijen P.C., Holstege F.C., et al. Possible role of the innate immunity in temporal lobe epilepsy. Epilepsia 2008, 49:1055-1065.
53. Stefulj J., Bordukalo-Niksic T., Hecimovic H., Demarin V., Jernej B. Epilepsy and serotonin (5HT): variations of 5HT-related genes in temporal lobe epilepsy. Neurosci Lett 2010, 478:29-31.
54. Estacion M., Gasser A., Dib-Hajj S.D., Waxman S.G. A sodium channel mutation linked to epilepsy increases ramp and persistent current of Nav1.3 and induces hyperexcitability in hippocampal neurons. Exp Neurol 2010, 224:362-368.
55. van Gassen K.L., de Wit M., van Kempen M., van der Hel W.S., van Rijen P.C., Jackson A.P., et al. Hippocampal Nabeta3 expression in patients with temporal lobe epilepsy. Epilepsia 2009, 50:957-962.
56. Maher J., McLachlan R.S. Febrile convulsions. Is seizure duration the most important predictor of temporal lobe epilepsy?. Brain 1995, 118(Pt 6):1521-1528.
57. Scheffer I.E., Harkin L.A., Grinton B.E., Dibbens L.M., Turner S.J., Zielinski M.A., et al. Temporal lobe epilepsy and GEFS+ phenotypes associated with SCN1B mutations. Brain 2007, 130:100-109.
58. Baulac S., Picard F., Herman A., Feingold J., Genin E., Hirsch E., et al. Evidence for digenic inheritance in a family with both febrile convulsions and temporal lobe epilepsy implicating chromosomes 18qter and 1q25-q31. Ann Neurol 2001, 49:786-792.
59. Claes L., Audenaert D., Deprez L., Van Paesschen W., Depondt C., Goossens D., et al. Novel locus on chromosome 12q22-q23. 3 responsible for familial temporal lobe epilepsy associated with febrile seizures. J Med Genet 2004, 41:710-714.
60. Hedera P., Blair M.A., Andermann E., Andermann F., D'Agostino D., Taylor K.A., et al. Familial mesial temporal lobe epilepsy maps to chromosome 4q13.2-q21.3. Neurology 2007, 68:2107-2112.
61. Jamali S., Salzmann A., Perroud N., Ponsole-Lenfant M., Cillario J., Roll P., et al. Functional variant in complement C3 gene promoter and genetic susceptibility to temporal lobe epilepsy and febrile seizures. PLoS One 2010, 5:9.
62. Colosimo E., Gambardella A., Mantegazza M., Labate A., Rusconi R., Schiavon E., et al. Electroclinical features of a family with simple febrile seizures and temporal lobe epilepsy associated with SCN1A loss-of-function mutation. Epilepsia 2007, 48:1691-1696.
63. Kwan P., Brodie M.J. Potential role of drug transporters in the pathogenesis of medically intractable epilepsy. Epilepsia 2005, 46:224-235.
64. Lachos J, Zattoni M, Wieser HG, Fritschy JM, Langmann T, Schmitz G, et al. Characterization of the gene expression profile of human hippocampus in mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsy research and treatment 2011;Article ID 758407.
65. Kauffman M.A., Consalvo D., Gonzalez-Moron D., Aguirre F., D'Alessio L., Kochen S. Serotonin transporter gene variation and refractory mesial temporal epilepsy with hippocampal sclerosis. Epilepsy Res 2009, 85:231-234.
66. Scheffer I.E., Phillips H.A., O'Brien C.E., Saling M.M., Wrennall J.A., Wallace R.H., et al. Familial partial epilepsy with variable foci: a new partial epilepsy syndrome with suggestion of linkage to chromosome 2. Ann Neurol 1998, 44:890-899.
67. Xiong L., Labuda M., Li D.S., Hudson T.J., Desbiens R., Patry G., et al. Mapping of a gene determining familial partial epilepsy with variable foci to chromosome 22q11-q12. Am J Hum Genet 1999, 65:1698-1710.
68. Callenbach P.M., van den Maagdenberg A.M., Hottenga J.J., van den Boogerd E.H., de Coo R.F., Lindhout D., et al. Familial partial epilepsy with variable foci in a Dutch family: clinical characteristics and confirmation of linkage to chromosome 22q. Epilepsia 2003, 44:1298-1305.
69. Diani E., Di Bonaventura C., Mecarelli O., Gambardella A., Elia M., Bovo G., et al. Autosomal dominant lateral temporal epilepsy: absence of mutations in ADAM22 and Kv1 channel genes encoding LGI1-associated proteins. Epilepsy Res 2008, 80:1-8.
70. Wenzel H.J., Vacher H., Clark E., Trimmer J.S., Lee A.L., Sapolsky R.M., et al. Structural consequences of Kcna1 gene deletion and transfer in the mouse hippocampus. Epilepsia 2007, 48:2023-2046.
71. Gu W., Sander T., Becker T., Steinlein O.K. Genotypic association of exonic LGI4 polymorphisms and childhood absence epilepsy. Neurogenetics 2004, 5:41-44.
72. Ishii A., Zhang B., Kaneko S., Hirose S. Positive association between benign familial infantile convulsions and LGI4. Brain Dev 2010, 32:538-543.
73. Lucarini N., Verrotti A., Napolioni V., Bosco G., Curatolo P. Genetic polymorphisms and idiopathic generalized epilepsies. Pediatr Neurol 2007, 37:157-164.
74. Ozkaynak E., Abello G., Jaegle M., van Berge L., Hamer D., Kegel L., et al. Adam22 is a major neuronal receptor for Lgi4-mediated Schwann cell signaling. J Neurosci 2010, 30:3857-3864.
75. Sagane K., Sugimoto H., Akaike A. Biological characterization of ADAM22 variants reveals the importance of a disintegrin domain sequence in cell surface expression. J Recept Signal Transduct Res 2010, 30:72-77.
76. Krishnakumar A., Nandhu M.S., Paulose C.S. Upregulation of 5-HT2C receptors in hippocampus of pilocarpine-induced epileptic rats: antagonism by Bacopa monnieri. Epilepsy Behav 2009, 16:225-230.
77. Pitsch J., Schoch S., Gueler N., Flor P.J., van der Putten H., Becker A.J. Functional role of mGluR1 and mGluR4 in pilocarpine-induced temporal lobe epilepsy. Neurobiol Dis 2007, 26:623-633.
78. Raol Y.H., Lund I.V., Bandyopadhyay S., Zhang G., Roberts D.S., Wolfe J.H., et al. Enhancing GABA(A) receptor alpha 1 subunit levels in hippocampal dentate gyrus inhibits epilepsy development in an animal model of temporal lobe epilepsy. J Neurosci 2006, 26:11342-11346.
79. Primeaux S.D., Holmes P.V. Olfactory bulbectomy increases met-enkephalin- and neuropeptide-Y-like immunoreactivity in rat limbic structures. Pharmacol Biochem Behav 2000, 67:331-337.
80. Noe F., Pool A.H., Nissinen J., Gobbi M., Bland R., Rizzi M., et al. Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy. Brain 2008, 131:1506-1515.
81. Sorensen A.T., Nikitidou L., Ledri M., Lin E.J., During M.J., Kanter-Schlifke I., et al. Hippocampal NPY gene transfer attenuates seizures without affecting epilepsy-induced impairment of LTP. Exp Neurol 2009, 215:328-333.
82. Bovolenta R., Zucchini S., Paradiso B., Rodi D., Merigo F., Mora G.N., et al. Hippocampal FGF-2 and BDNF overexpression attenuates epileptogenesis-associated neuroinflammation and reduces spontaneous recurrent seizures. J Neuroinflam 2010, 7.
83. Paradiso B., Marconi P., Zucchini S., Berto E., Binaschi A., Bozac A., et al. Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model. Proc Natl Acad Sci USA 2009, 106:7191-7196.
84. Maisano X., Carpentino J., Becker S., Lanza R., Aaron G., Grabel L., et al. Embryonic stem cell-derived neural precursor grafts for treatment of temporal lobe epilepsy. Neurotherapeutics 2009, 6:263-277.
85. Ottman R., Hirose S., Jain S., Lerche H., Lopes-Cendes I., Noebels J.L., et al. Genetic testing in the epilepsies - report of the ILAE Genetics Commission. Epilepsia 2010, 51(4):655-670.
86. Hartman JLt, Garvik B., Hartwell L. Principles for the buffering of genetic variation. Science 2001, 291(5506):1001-1004.
87. Berkovic S.F., Mulley J.C., Scheffer I.E., Petrou S. Human epilepsies: interaction of genetic and acquired factors. Trends Neurosci 2006, 29:391-397.
88. Tan N.C., Mulley J.C., Scheffer I.E. Genetic dissection of the common epilepsies. Curr Opin Neurol 2006, 19:157-163.
89. Dalby N.O., Mody I. The process of epileptogenesis: a pathophysiological approach. Curr Opin Neurol 2001, 14:187-192.
90. Bender R.A., Dube C., Baram T.Z. Febrile seizures and mechanisms of epileptogenesis: insights from an animal model. Adv Exp Med Biol 2004, 548:213-225.
91. Scimemi A., Schorge S., Kullmann D.M., Walker M.C. Epileptogenesis is associated with enhanced glutamatergic transmission in the perforant path. J Neurophysiol 2006, 95:1213-1220.